Western blot analysis of CXCR4 protein expression with N- and C-terminal directed antibodies. Western blot analysis of CXCr4 protein expression in high CXCR4 expressing Ewing sarcoma cell line IARC-EW3, medium CXCR4 expressing breast cancer cell line MDA-MB-468 and low CXCR4 expressing Ewing cell line IARC-EW7 (supplementary results [10]) using two N-terminal antibodies (Ab2074 and NBP1–76867) and one C-terminal antibody (UMB2). Theoretical molecular weight of CXCR4–2 is 39 kDa. No conclusive results could be obtained with any of these antibodies. (EPS 959 kb
Table S1. Data description of TCGA RNA sequencing data. Table S2. List of antibody-drug conjugates. ...
Western blot analysis of protein level in paired colorectal carcinoma (CRC) and normal colon mucosae...
List of antibodies and sources for use in immunofluorescent staining, co-immunoprecipitation, wester...
CXCR4 expression profiling in different cell lines. CXCR4 expression was performed using the 2B11 CX...
Validation to show the effect of cell harvesting procedure on detected MSAP-Ac-TZ14011 and ab2074 si...
Quantification of immunostaining of CXCR4 and CXCL12 protein by digital image analysis. (A) The numb...
Influence of methanol fixation after MSAP-Ac-TZ14011 staining. EWS cell line A673 and MDA-MB-231 X4 ...
Figure S1. Granulocyte-colony stimulating factor and DMSO vehicle do not induce proliferation of Ewi...
Figure S4. Length of potential binding neoepitopes in breast cancer. The number of potential binding...
PF-06747143 and its Fab and F(ab’)2 forms block CXCL12-induced calcium flux. The calcium flux assay ...
Correlations between inflammatory cell grading (CD4/CD8/CD68 staining) and the percentages of inflam...
Table S1. Plerixafor treatment changes receptor tyrosine kinase phosphorylation patterns in CXCR4-hi...
MTS, migration and invasion assays in ductal carcinoma in situ (DCIS) BCL9-KD cells with shRNA 2. A ...
S2 Antibody target specificity is unaffected by sequence of primary antibody application. Merged (ri...
Figure S6. Box plots comparing the expression of ERBB2, AR and RB1 genes split by PAM50 subtypes in ...
Table S1. Data description of TCGA RNA sequencing data. Table S2. List of antibody-drug conjugates. ...
Western blot analysis of protein level in paired colorectal carcinoma (CRC) and normal colon mucosae...
List of antibodies and sources for use in immunofluorescent staining, co-immunoprecipitation, wester...
CXCR4 expression profiling in different cell lines. CXCR4 expression was performed using the 2B11 CX...
Validation to show the effect of cell harvesting procedure on detected MSAP-Ac-TZ14011 and ab2074 si...
Quantification of immunostaining of CXCR4 and CXCL12 protein by digital image analysis. (A) The numb...
Influence of methanol fixation after MSAP-Ac-TZ14011 staining. EWS cell line A673 and MDA-MB-231 X4 ...
Figure S1. Granulocyte-colony stimulating factor and DMSO vehicle do not induce proliferation of Ewi...
Figure S4. Length of potential binding neoepitopes in breast cancer. The number of potential binding...
PF-06747143 and its Fab and F(ab’)2 forms block CXCL12-induced calcium flux. The calcium flux assay ...
Correlations between inflammatory cell grading (CD4/CD8/CD68 staining) and the percentages of inflam...
Table S1. Plerixafor treatment changes receptor tyrosine kinase phosphorylation patterns in CXCR4-hi...
MTS, migration and invasion assays in ductal carcinoma in situ (DCIS) BCL9-KD cells with shRNA 2. A ...
S2 Antibody target specificity is unaffected by sequence of primary antibody application. Merged (ri...
Figure S6. Box plots comparing the expression of ERBB2, AR and RB1 genes split by PAM50 subtypes in ...
Table S1. Data description of TCGA RNA sequencing data. Table S2. List of antibody-drug conjugates. ...
Western blot analysis of protein level in paired colorectal carcinoma (CRC) and normal colon mucosae...
List of antibodies and sources for use in immunofluorescent staining, co-immunoprecipitation, wester...